# Clinical Characteristics of 1378 Inpatients with Spinal Tuberculosis in General Hospitals in South-Central China

Authors: Zheng Liu; Jun Wang; Gong-Zhou Chen; Wei-Wei Li; Yun-Qi Wu; Xiao Xiao; Yi-Lu Zhang; Yan Yang; Wen-Kai Hu; Zhi-Cheng Sun; Xi-Yang Wang
Journal: BioMed Research International
 (2019)

---

## Abstract

In this retrospective study, charts of inpatients with spinal tuberculosis (STB) treated in large-scale general hospitals in Changsha, Hunan, China, between 2007 and 2016 were reviewed to investigate their clinical characteristics. Demographic, epidemiological and clinical features, imaging findings, treatment methods, and prognosis were summarized and analyzed. There were 1378 patients, 805 males and 573 females, with a mean age of 43.7 years. The mean interval between symptom onset and diagnosis was 16.0 months (range 15 days–240 months). The incidence of back pain, radicular pain and symptoms of systemic toxicity was 92.5%, 40.1%, and 32.1%, respectively. The rate of neurological impairment was 49.9 %. STB was present in two or more vertebrae in 91.1% of patients, with two adjacent vertebrae being involved in 67.9% of them. The lumbar segment (38.2%) was the most frequently affected, followed by the thoracic spine (35.7%). The sacrococcygeal area was the least frequently involved (0.8%). Abscesses were detected in 65.5% of patients. One thousand patients (72.6%) were managed with surgery and 378 (27.4%) with anti-TB drugs only. Cure was achieved in 1215 patients (88.2%), whereas 49 (3.5 %) had relapses. Concomitant pulmonary TB (PTB) was diagnosed in 366 patients (26.6%) and 63 (4.6%) had concomitant diabetes. Compared with the previous five years, the number of older patients, urban patients, and medical staff with STB had increased by 6.1%, 5.2%, and 1.3%, respectively in the five years studied. STB remains a severe public health problem that cannot be ignored. Most of the patients ignored early symptoms and therefore received untimely treatment. Thus, surveillance for and treatment of STB in South-central China requires strengthening. In addition to the current China-wide database of patients with PTB, a China-wide database of patients with STB should also be set up.


---

## Body

## 1. Introduction

According to a 2018 report of the World Health Organization (WHO) [1], although the incidence and mortality of tuberculosis (TB) in China have been declining slowly in recent years, China still had the second highest burden of TB in the world, with about 889,000 new cases of TB and 388,000 deaths in 2017, second only to India. Thus, TB is still a major problem, endangering the health of Chinese people.Spinal tuberculosis (STB), which accounts for half of bone and joint TB and is the most common form of extrapulmonary TB, often leads to irreversible neurological injury, including paralysis, resulting in serious social and economic problems [2]. STB is a chronic disease that is slowly progressive, and diagnosing it is relatively difficult [3].Progression of STB may cause spinal deformity and neurological injury, including paralysis, which seriously affect the quality of lives of affected patients and are difficult to cure by chemotherapy drugs. Anti-TB drug chemotherapy is the major means of treating STB and is the fundamental means of curing STB, with surgery being an adjuvant means of treatment [4, 5].Clinical data concerning TB differ according to differences in geographical locations, life style, level of economic development, level of available medical services, and other factors. In Hunan province, located in south-central China, there is a high incidence (83.0/10 million) and high number of reported cases (55,919 cases) of pulmonary tuberculosis (PTB), resulting in this province ranking in the top eight and three provinces of China, respectively (data obtained from the notifiable PTB report of the Chinese Infectious Disease Report System [IDRS]). A number of epidemiological studies of PTB in Hunan have been published, but none concerning STB. This is also true for throughout China.In this study, clinical data of inpatients with STB in Changsha, Hunan, from 2007 to 2016, including general information, symptoms of TB, diagnosis, treatment, and prognosis, were collected and analyzed to help in the prevention, diagnosis, treatment, and prognosis of STB in Hunan province.


## 2. Materials and Methods

### 2.1. Patients Survey

In this retrospective study, the medical records of inpatients admitted for STB to several large comprehensive hospitals in Changsha, Hunan, China, from January 2007 to December 2016 were collected and reviewed.Diagnosis of STB was established by clinical, laboratory, and imaging investigations supplemented by pathological examination of biopsy specimens. The diagnosis was based on the following criteria:(1) clinical symptoms and signs such as backache, spinal deformity, neurological deficit (numbness, weakness, dysesthesia, dyskinesia, and paralysis), systemic toxicity symptoms (STS) of TB, including low-grade fever, night sweats and emaciation; (2) computed tomography (CT) and magnetic resonance imaging (MRI) manifestations, such as destruction of vertebral bone, intervertebral space involvement, kyphosis, paravertebral abscess formation, and dural sac compression; (3) laboratory findings including high erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) concentration, positive T-SPOT, TB antibody (IgG and IgM), and tuberculin test; (4) diagnostic anti-TB treatment was effective when it was difficult to otherwise make a definite diagnosis; (5) pathological evidence of TB, such as typical TB with caseous necrosis microscopically, was regarded as the golden standard of diagnosis.All patients who were diagnosed with STB were routinely treated with the HREZ anti-TB chemotherapy regimen for 12–18 months, namely, rifampicin (450 mg/day), isoniazid (300 mg/day), ethambutol (750 mg/day), and pyrazinamide (750 mg/day). Kidney function and liver function were monitored during anti-TB chemotherapy.Indications for surgery for STB were as follows:(1) progressive or severe neurological damage, (2) bone destruction of various degrees with severe or developing spinal deformity, (3) persistent back pain due to spinal instability, and (4) poor response to medical treatment.


### 2.2. Clinical Data

On hospital admission, personal characteristics, clinical manifestations, imaging findings, comorbidities, treatment, and prognostic indicators were collected and analyzed. Patients with missing personal, clinical, or examination data were excluded from the study. Detailed clinical data, including sex, age, place of residence (rural versus urban), occupation, local pain, radicular pain, STS, abscess, neurological injury, involved vertebrae, locations of lesions, concomitant PTB or diabetes, and treatment, were summarized. The American Spinal Injury Association (ASIA) impairment scale was applied to score neurological function. Correlations between variables and years of study were analyzed.Patients with STB were divided into two groups according to the year of admission, Group A from January 2007 to December 2011 and Group B from January 2012 to December 2016, and variables were assessed comparing the two groups. Trends in changes of each variable were summarized. Because STB is considered to originate from PTB and diabetes is a common comorbidity of STB, correlations between PTB, diabetes, and STB were analyzed.Follow-up information was obtained by telephone, through e-mail, and during return visits to the outpatient department. “Cure” was defined as follows: no recurrence of TB lesions within 2 years after treatment, maintenance of ESR within the normal range, identification of bone union in lesions by radiographic examination, and disappearance of clinical symptoms for 3 months.[6]


### 2.3. Statistical Analysis

Statistical analysis of the experimental data was performed with theχ2 test using SPSS 24.0 software (SPSS, Chicago, IL, USA). P < 0.05 was considered to denote significant differences.


## 2.1. Patients Survey

In this retrospective study, the medical records of inpatients admitted for STB to several large comprehensive hospitals in Changsha, Hunan, China, from January 2007 to December 2016 were collected and reviewed.Diagnosis of STB was established by clinical, laboratory, and imaging investigations supplemented by pathological examination of biopsy specimens. The diagnosis was based on the following criteria:(1) clinical symptoms and signs such as backache, spinal deformity, neurological deficit (numbness, weakness, dysesthesia, dyskinesia, and paralysis), systemic toxicity symptoms (STS) of TB, including low-grade fever, night sweats and emaciation; (2) computed tomography (CT) and magnetic resonance imaging (MRI) manifestations, such as destruction of vertebral bone, intervertebral space involvement, kyphosis, paravertebral abscess formation, and dural sac compression; (3) laboratory findings including high erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) concentration, positive T-SPOT, TB antibody (IgG and IgM), and tuberculin test; (4) diagnostic anti-TB treatment was effective when it was difficult to otherwise make a definite diagnosis; (5) pathological evidence of TB, such as typical TB with caseous necrosis microscopically, was regarded as the golden standard of diagnosis.All patients who were diagnosed with STB were routinely treated with the HREZ anti-TB chemotherapy regimen for 12–18 months, namely, rifampicin (450 mg/day), isoniazid (300 mg/day), ethambutol (750 mg/day), and pyrazinamide (750 mg/day). Kidney function and liver function were monitored during anti-TB chemotherapy.Indications for surgery for STB were as follows:(1) progressive or severe neurological damage, (2) bone destruction of various degrees with severe or developing spinal deformity, (3) persistent back pain due to spinal instability, and (4) poor response to medical treatment.


## 2.2. Clinical Data

On hospital admission, personal characteristics, clinical manifestations, imaging findings, comorbidities, treatment, and prognostic indicators were collected and analyzed. Patients with missing personal, clinical, or examination data were excluded from the study. Detailed clinical data, including sex, age, place of residence (rural versus urban), occupation, local pain, radicular pain, STS, abscess, neurological injury, involved vertebrae, locations of lesions, concomitant PTB or diabetes, and treatment, were summarized. The American Spinal Injury Association (ASIA) impairment scale was applied to score neurological function. Correlations between variables and years of study were analyzed.Patients with STB were divided into two groups according to the year of admission, Group A from January 2007 to December 2011 and Group B from January 2012 to December 2016, and variables were assessed comparing the two groups. Trends in changes of each variable were summarized. Because STB is considered to originate from PTB and diabetes is a common comorbidity of STB, correlations between PTB, diabetes, and STB were analyzed.Follow-up information was obtained by telephone, through e-mail, and during return visits to the outpatient department. “Cure” was defined as follows: no recurrence of TB lesions within 2 years after treatment, maintenance of ESR within the normal range, identification of bone union in lesions by radiographic examination, and disappearance of clinical symptoms for 3 months.[6]


## 2.3. Statistical Analysis

Statistical analysis of the experimental data was performed with theχ2 test using SPSS 24.0 software (SPSS, Chicago, IL, USA). P < 0.05 was considered to denote significant differences.


## 3. Results

### 3.1. Demographic, Epidemiological, and Personal Characteristics

During the years of this study, there were 1378 eligible inpatients with STB. Table1 shows the demographic, epidemiological, and personal characteristics of the study patients. During this 10-year period, the incidence of STB was relatively stable (116–170 new cases per year). The study cohort comprised 805 (58.4%) male and 573 (41.6%) female patients. In the 10 years of the study, there were always more male than female patients. Additionally, there was no significant difference in the ratio of male to female during these 10 years (P > 0.05).Table 1
Demographics and epidemiology of inpatients with STB.
Year Gender Age (yeas) Residence Occupation Total Male Female <18 18~45 46~60 >60 Rural Urban Farmer Worker Student Others 2007 70 46 7 53 42 14 84 32 59 24 10 23 116 2008 82 56 11 58 41 28 96 42 67 30 12 29 138 2009 65 58 15 52 33 23 91 32 65 22 16 20 123 2010 86 60 10 66 38 32 122 24 75 24 14 33 146 2011 75 56 6 61 33 31 101 30 71 21 9 30 131 2012 91 60 10 71 31 39 115 36 69 30 13 39 151 2013 79 69 13 59 43 33 99 49 65 28 14 41 148 2014 75 46 6 42 47 26 76 45 56 21 7 47 121 2015 101 69 11 63 46 50 122 48 79 27 17 47 170 2016 81 53 11 36 49 38 97 37 53 32 16 33 134  Total 805 573 100 561 403 314 1003 375 659 259 128 332 1378 Rate (%) 58.4 41.6 7.3 40.7 29.2 22.8 72.8 27.2 47.8 18.8 9.3 24.1 χ2 4.583 46.592 20.252 30.756 P 0.869 0.011 0.016  0.281The age range was 1–88 years, with the mean age being 43.7 years. Specifically, 561 patients (40.7%) were aged from 18 to 45 years, followed by the 46–60 years-old (27.2%). As to place of residence, urban patients accounted for 29.2% (375/1378) and rural patients 72.8% (1003/1378) of the cohort. The mean interval between symptom onset and diagnosis in the hospital was 16.0 months (range 15 days–240 months), this interval being a mean of 22.0 months in rural patients and 9.6 months in urban patients; this difference is significant (P<0.05). In addition, the distribution of patients with STB in various cities of Hunan province is shown in Figure1 (Changsha, 15.53%; Shaoyang, 11.68%; Yueyang, 9.43%; Yiyang, 9.29%; Loudi, 8.78%; Yongzhou, 8.06%; Hengyang, 6.68%; Zhuzhou, 6.46%; Changde, 5.95%; Xiangtan, 3.70%; Zhangjiajie, 3.05%; Chenzhou, 2.18%; Huaihua, 2.98%; Xiangxi, 1.89%). The remaining 4.35% were from Jiangxi and Guizhou province, both adjoining Hunan province.Figure 1
The distribution of patients with STB in Hunan province is shown: 214 (15.53%) were from Changsha (J), 161 (11.68%) from Shaoyang (G), 130 (9.43%) from Yueyang (D), 128 (9.29%) from Yiyang (E), 121 (8.78%) from Loudi (H), 111 (8.06%) from Yongzhou (M), 92 (6.68%) from Hengyang (L), 89 (6.46%) from Zhuzhou (K), 82 (5.95%) from Changde (C), 51(3.70%) from Xiangtan (I), 42 (3.05%) from Zhangjiajie (B), 30 (2.18%) from Chenzhou (N), 41 (2.98%) from Huaihua (F), and 26 (1.89%) from Xiangxi (A).As to distribution of occupations, there were 659 farmers (47.8%), 259 manual workers (18.8%), 128 students (9.3%), and 332 with other occupations (24.1%). The correlation between occupations and years `was analyzed. Distribution of occupation did not differ significantly over time (P > 0.05).


### 3.2. Clinical Presentation

As to the clinical presentation of patients with STB (Table2), 92.5% presented with back pain and the remaining 7.5% with spinal deformity or numbness in the limbs without back pain. The incidences of radicular pain and STS in patients with STB were 40.1% and 32.1%, respectively. Analysis of correlations between back pain and radicular pain and year of study showed no significant change in the incidence of these symptoms over the 10 years (P > 0.05). As to distribution of severity of neurological injury, 21 (1.5%) patients had ASIA Grade A deficits, 38 (2.8%) Grade B, 111 (8.1%) Grade C, 517 (37.5%) Grade D, and 691 (50.1%) Grade E.Table 2
Clinical presentation of inpatients with STB.
Year Back pain Radiating pain Systemic toxicity symptoms Neurological injury (ASIA grade) Yes No Yes No Yes No A B C D E 2007 108 8 55 61 38 78 2 3 6 50 55 2008 127 11 60 78 47 91 1 2 10 58 67 2009 109 14 49 74 39 84 2 2 14 40 65 2010 134 12 51 95 44 102 1 3 13 64 65 2011 118 13 49 82 47 84 3 2 13 50 63 2012 142 9 52 99 66 85 4 5 12 52 78 2013 139 9 59 89 37 111 2 6 8 61 71 2014 116 5 56 65 29 92 1 3 11 33 73 2015 154 16 56 114 52 118 2 6 9 52 101 2016 128 6 65 69 44 90 3 6 15 57 53  Total 1275 103 552 826 443 935 21 38 111 517 691 Rate (%) 92.5 7.5 40.1 59.9 32.1 67.9 1.5 2.8 8.1 37.5 50.1 χ2 9.607 16.782 18.017 26.902 P 0.383 0.052 0.035 0.081


### 3.3. Imaging Findings

As shown in Table3, the lumbar segment was the most frequently affected site (38.2%), followed by the thoracic (35.7%), lumbosacral (8.0%), thoracolumbar (7.9%), cervical (6.4%), and cervicothoracic spines (3.0%), the sacrococcygeal area being the least frequently involved (0.8%). There was STB in two or more vertebrae in 91.1% of patients, in 67.9% of whom two adjacent vertebrae were involved. Abscesses were detected by CT or MRI in 903 of 1378 patients (65.5%), including paraspinal, prevertebral and psoas abscesses.Table 3
Imaging findings of inpatients with STB.
Year Lesion sites Involved number of vertebrae Abscess C CT T TL L LS S 1 2 ≧3 With Without 2007 6 5 53 7 39 6 0 10 81 25 75 41 2008 8 8 59 11 40 11 1 16 92 30 87 51 2009 5 4 49 16 39 9 1 12 86 25 80 43 2010 11 3 59 12 47 13 1 17 104 25 98 48 2011 2 7 52 12 47 9 2 6 85 40 89 42 2012 8 1 55 10 60 14 3 13 101 37 109 42 2013 11 3 49 9 68 8 0 14 97 37 90 58 2014 12 2 28 14 52 12 1 10 79 32 81 40 2015 12 2 53 10 80 11 2 15 124 31 112 58 2016 13 6 35 8 55 17 0 10 86 38 82 52  Total 88 41 492 109 527 110 11 123 935 320 903 475 Rate (%) 6.4 3.0 35.7 7.9 38.2 8.0 0.8 8.9 67.9 23.2 65.5 34.5 χ2 81.027 17.655 6.582 P 0.01 0.479 0.681 C: Cervical; CT: Cervicothoracic; T: Thoracic; TL: Thoracolumbar; L: Lumbar; LS: Lumbosacral; S: Sacrococcygeal.


### 3.4. Treatment and Prognosis

As to distribution of treatment (Figure2), 1000 patients (72.6%) were treated surgically and 378 (27.4%) with anti-TB drugs only. The proportion of patients undergoing surgery did not differ significantly over the 10 years of the study (P > 0.05). The surgical approach (single anterior, single posterior, or combined anterior–posterior approach) was selected on the basis of each patient’s condition. Minimally invasive CT-guided percutaneous catheter drainage and focal catheter infusion was used in patients with huge iliopsoas abscesses; these procedures are included in the surgical group.Figure 2
Number of patients treated by surgery or anti-TB chemotherapy only in each year.As to distribution of prognosis (Figure3), 1215 patients (88.2%) gradually achieved cure within 18 months after hospital admission and initiation of treatment. The 49 patients (3.5%) who relapsed all had postoperative recurrences and required retreatment in hospital. Relapses were presented as postoperative recurrence of TB lesions, abscess formation, sinus formation, progressive kyphosis, or internal fixation fractures, all of which were treated by revision surgery. Follow-up data on the other 114 patients (8.3%) were incomplete. They included patients who were transferred to specialized TB hospitals, those with lost contact, those not cured, and those who died. Poor compliance was the main reason for patients not achieving cure. One death was due to systemic infection.Figure 3
Number of patients with various outcomes in each year.


### 3.5. Comorbidities

Concomitant PTB, including a previous history of PTB, was present in 366 (26.6%) patients (Figure4), whereas 63 patients (4.6%) had concomitant diabetes (Figure 5). The proportion of patients with STB accompanied by PTB or diabetes did not differ significantly over the 10 study years (P > 0.05). Among other complications, two patients with thoracolumbar STB had accompanying renal TB and one with cervical STB had accompanying lymph node TB. None of the patients in this study were HIV-positive.Figure 4
Number of patients with and without concomitant PTB in each year.Figure 5
Number of patients with and without concomitant diabetes in each year.Correlations between various variables and STB and PTB are shown in Table4. Of the patients with PTB, 63.4% were males, 70.8% had accompanying abscesses, 37.7% had STS, 56.6% had accompanying neurological damage, and 61.2% received non-surgical treatment only. Sex, abscess, STS, neurological injury, and surgery were positively correlated with PTB (P < 0.05). The cure rate did not differ significantly between patients with and without PTB (P > 0.05).Table 4
Correlation analysis between STB and PTB.
Variate Type Without PTB With PTB Total χ2 P N % N % Gender Male 573 56.6 232 63.4 805 5.068 0.024 Female 439 43.4 134 36.6 573 Abscess Yes 644 63.6 259 70.8 903 6.047 0.014 No 368 36.4 107 29.2 475 Surgery Yes 776 76.7 224 61.2 1000 32.347 0.000 No 236 23.3 142 38.8 378 Systemic toxicity symptoms Yes 305 30.1 138 37.7 443 7.055 0.008 No 707 69.9 228 62.3 935 Neurological injury Yes 480 47.4 207 56.6 687 8.955 0.003 No 532 52.6 159 43.4 691 Prognosis Cure 891 88.0 319 87.2 1214 0.490 0.484 Others 121 12.0 47 12.8 163Of the patients with concomitant diabetes, 87.3% were middle-aged or older, 44.4 % had STS, 46.0% required non-surgical treatment only, and the cure rate was 76.2% (Table5). Age, STS, surgery and prognosis were correlated with the presence of diabetes (P < 0.05).Table 5
Correlation analysis between STB and diabetes.
Variate Type Without diabetes With diabetes Total χ2 P N % N % Age (yeas) >45 662 50.3 55 87.3 717 32.904 0.000 ≦45 653 49.7 8 12.7 661 Systemic toxicity symptoms Yes 415 31.6 28 44.4 443 4.576 0.032 No 900 68.4 35 55.6 935 Surgery Yes 966 73.4 34 54.0 1000 11.474 0.001 No 349 26.6 29 46.0 378 Prognosis Cure 1167 88.7 48 76.2 1215 9.086 0.003 Others 148 11.3 15 23.8 163


### 3.6. Comparison of Data according to Time Period

Comparisons of data in the first and second group of 5 years are shown in Table6. Group A (January 2007–December 2011) comprised 654 patients and Group B (January 2012–December 2016) 724. There was a greater proportion of patients aged over 60 years, urban patients, and medical staff with STB in Group B than in Group A (P < 0.05), the proportion of older patients, urban patients, and medical staff with STB having increased by 6.1%, 5.2%, and 1.3%, respectively.Table 6
Comparison of 10 years' data.
Variate Type Group A Group B Total χ2 P (2007-2011) (2012-2016) N % N % Gender Male 378 57.8 427 59 805 0.197 0.657 Female 276 42.2 297 41 573 Age (yeas) ≦60 526 80.4 538 74.3 1064 7.312 0.007 >60 128 19.6 186 25.7 314 Residence Rural 494 75.5 509 70.3 1003 4.747 0.029 Urban 160 24.5 215 29.7 375 Occupation Medical staff 6 0.9 16 2.2 22 4.154 0.046 Others 648 99.1 708 97.8 1356 Back pain Yes 596 91.1 679 93.8 1275 3.497 0.061 No 58 8.9 45 6.2 103 Radicular pain Yes 264 40.4 288 39.6 552 0.049 0.825 No 390 59.6 436 60.4 826 Systemic toxicity symptoms Yes 215 32.9 228 31.5 443 0.301 0.583 No 439 67.1 496 68.5 935 Abscess Yes 429 65.6 474 65.5 903 0.002 0.964 No 225 34.4 250 34.5 475 Neurological injury Yes 339 51.8 348 48.1 687 1.952 0.162 No 315 48.2 376 51.9 691 Involved number of vertebrae <3 509 77.8 549 75.9 1058 0.771 0.380 ≧3 145 22.2 175 24.1 320 Surgery Yes 488 68.5 512 70.7 1000 2.625 0.105 No 166 31.5 212 29.3 378 PTB Yes 176 26.9 190 26.2 366 0.079 0.779 No 478 73.1 534 73.8 1012 Diabetes Yes 23 3.5 40 5.5 63 3.176 0.075 No 631 96.5 684 94.5 1315 Prognosis Cure 567 86.7 648 89.5 1215 2.593 0.107 Others 87 13.3 76 11.9 163


## 3.1. Demographic, Epidemiological, and Personal Characteristics

During the years of this study, there were 1378 eligible inpatients with STB. Table1 shows the demographic, epidemiological, and personal characteristics of the study patients. During this 10-year period, the incidence of STB was relatively stable (116–170 new cases per year). The study cohort comprised 805 (58.4%) male and 573 (41.6%) female patients. In the 10 years of the study, there were always more male than female patients. Additionally, there was no significant difference in the ratio of male to female during these 10 years (P > 0.05).Table 1
Demographics and epidemiology of inpatients with STB.
Year Gender Age (yeas) Residence Occupation Total Male Female <18 18~45 46~60 >60 Rural Urban Farmer Worker Student Others 2007 70 46 7 53 42 14 84 32 59 24 10 23 116 2008 82 56 11 58 41 28 96 42 67 30 12 29 138 2009 65 58 15 52 33 23 91 32 65 22 16 20 123 2010 86 60 10 66 38 32 122 24 75 24 14 33 146 2011 75 56 6 61 33 31 101 30 71 21 9 30 131 2012 91 60 10 71 31 39 115 36 69 30 13 39 151 2013 79 69 13 59 43 33 99 49 65 28 14 41 148 2014 75 46 6 42 47 26 76 45 56 21 7 47 121 2015 101 69 11 63 46 50 122 48 79 27 17 47 170 2016 81 53 11 36 49 38 97 37 53 32 16 33 134  Total 805 573 100 561 403 314 1003 375 659 259 128 332 1378 Rate (%) 58.4 41.6 7.3 40.7 29.2 22.8 72.8 27.2 47.8 18.8 9.3 24.1 χ2 4.583 46.592 20.252 30.756 P 0.869 0.011 0.016  0.281The age range was 1–88 years, with the mean age being 43.7 years. Specifically, 561 patients (40.7%) were aged from 18 to 45 years, followed by the 46–60 years-old (27.2%). As to place of residence, urban patients accounted for 29.2% (375/1378) and rural patients 72.8% (1003/1378) of the cohort. The mean interval between symptom onset and diagnosis in the hospital was 16.0 months (range 15 days–240 months), this interval being a mean of 22.0 months in rural patients and 9.6 months in urban patients; this difference is significant (P<0.05). In addition, the distribution of patients with STB in various cities of Hunan province is shown in Figure1 (Changsha, 15.53%; Shaoyang, 11.68%; Yueyang, 9.43%; Yiyang, 9.29%; Loudi, 8.78%; Yongzhou, 8.06%; Hengyang, 6.68%; Zhuzhou, 6.46%; Changde, 5.95%; Xiangtan, 3.70%; Zhangjiajie, 3.05%; Chenzhou, 2.18%; Huaihua, 2.98%; Xiangxi, 1.89%). The remaining 4.35% were from Jiangxi and Guizhou province, both adjoining Hunan province.Figure 1
The distribution of patients with STB in Hunan province is shown: 214 (15.53%) were from Changsha (J), 161 (11.68%) from Shaoyang (G), 130 (9.43%) from Yueyang (D), 128 (9.29%) from Yiyang (E), 121 (8.78%) from Loudi (H), 111 (8.06%) from Yongzhou (M), 92 (6.68%) from Hengyang (L), 89 (6.46%) from Zhuzhou (K), 82 (5.95%) from Changde (C), 51(3.70%) from Xiangtan (I), 42 (3.05%) from Zhangjiajie (B), 30 (2.18%) from Chenzhou (N), 41 (2.98%) from Huaihua (F), and 26 (1.89%) from Xiangxi (A).As to distribution of occupations, there were 659 farmers (47.8%), 259 manual workers (18.8%), 128 students (9.3%), and 332 with other occupations (24.1%). The correlation between occupations and years `was analyzed. Distribution of occupation did not differ significantly over time (P > 0.05).


## 3.2. Clinical Presentation

As to the clinical presentation of patients with STB (Table2), 92.5% presented with back pain and the remaining 7.5% with spinal deformity or numbness in the limbs without back pain. The incidences of radicular pain and STS in patients with STB were 40.1% and 32.1%, respectively. Analysis of correlations between back pain and radicular pain and year of study showed no significant change in the incidence of these symptoms over the 10 years (P > 0.05). As to distribution of severity of neurological injury, 21 (1.5%) patients had ASIA Grade A deficits, 38 (2.8%) Grade B, 111 (8.1%) Grade C, 517 (37.5%) Grade D, and 691 (50.1%) Grade E.Table 2
Clinical presentation of inpatients with STB.
Year Back pain Radiating pain Systemic toxicity symptoms Neurological injury (ASIA grade) Yes No Yes No Yes No A B C D E 2007 108 8 55 61 38 78 2 3 6 50 55 2008 127 11 60 78 47 91 1 2 10 58 67 2009 109 14 49 74 39 84 2 2 14 40 65 2010 134 12 51 95 44 102 1 3 13 64 65 2011 118 13 49 82 47 84 3 2 13 50 63 2012 142 9 52 99 66 85 4 5 12 52 78 2013 139 9 59 89 37 111 2 6 8 61 71 2014 116 5 56 65 29 92 1 3 11 33 73 2015 154 16 56 114 52 118 2 6 9 52 101 2016 128 6 65 69 44 90 3 6 15 57 53  Total 1275 103 552 826 443 935 21 38 111 517 691 Rate (%) 92.5 7.5 40.1 59.9 32.1 67.9 1.5 2.8 8.1 37.5 50.1 χ2 9.607 16.782 18.017 26.902 P 0.383 0.052 0.035 0.081


## 3.3. Imaging Findings

As shown in Table3, the lumbar segment was the most frequently affected site (38.2%), followed by the thoracic (35.7%), lumbosacral (8.0%), thoracolumbar (7.9%), cervical (6.4%), and cervicothoracic spines (3.0%), the sacrococcygeal area being the least frequently involved (0.8%). There was STB in two or more vertebrae in 91.1% of patients, in 67.9% of whom two adjacent vertebrae were involved. Abscesses were detected by CT or MRI in 903 of 1378 patients (65.5%), including paraspinal, prevertebral and psoas abscesses.Table 3
Imaging findings of inpatients with STB.
Year Lesion sites Involved number of vertebrae Abscess C CT T TL L LS S 1 2 ≧3 With Without 2007 6 5 53 7 39 6 0 10 81 25 75 41 2008 8 8 59 11 40 11 1 16 92 30 87 51 2009 5 4 49 16 39 9 1 12 86 25 80 43 2010 11 3 59 12 47 13 1 17 104 25 98 48 2011 2 7 52 12 47 9 2 6 85 40 89 42 2012 8 1 55 10 60 14 3 13 101 37 109 42 2013 11 3 49 9 68 8 0 14 97 37 90 58 2014 12 2 28 14 52 12 1 10 79 32 81 40 2015 12 2 53 10 80 11 2 15 124 31 112 58 2016 13 6 35 8 55 17 0 10 86 38 82 52  Total 88 41 492 109 527 110 11 123 935 320 903 475 Rate (%) 6.4 3.0 35.7 7.9 38.2 8.0 0.8 8.9 67.9 23.2 65.5 34.5 χ2 81.027 17.655 6.582 P 0.01 0.479 0.681 C: Cervical; CT: Cervicothoracic; T: Thoracic; TL: Thoracolumbar; L: Lumbar; LS: Lumbosacral; S: Sacrococcygeal.


## 3.4. Treatment and Prognosis

As to distribution of treatment (Figure2), 1000 patients (72.6%) were treated surgically and 378 (27.4%) with anti-TB drugs only. The proportion of patients undergoing surgery did not differ significantly over the 10 years of the study (P > 0.05). The surgical approach (single anterior, single posterior, or combined anterior–posterior approach) was selected on the basis of each patient’s condition. Minimally invasive CT-guided percutaneous catheter drainage and focal catheter infusion was used in patients with huge iliopsoas abscesses; these procedures are included in the surgical group.Figure 2
Number of patients treated by surgery or anti-TB chemotherapy only in each year.As to distribution of prognosis (Figure3), 1215 patients (88.2%) gradually achieved cure within 18 months after hospital admission and initiation of treatment. The 49 patients (3.5%) who relapsed all had postoperative recurrences and required retreatment in hospital. Relapses were presented as postoperative recurrence of TB lesions, abscess formation, sinus formation, progressive kyphosis, or internal fixation fractures, all of which were treated by revision surgery. Follow-up data on the other 114 patients (8.3%) were incomplete. They included patients who were transferred to specialized TB hospitals, those with lost contact, those not cured, and those who died. Poor compliance was the main reason for patients not achieving cure. One death was due to systemic infection.Figure 3
Number of patients with various outcomes in each year.


## 3.5. Comorbidities

Concomitant PTB, including a previous history of PTB, was present in 366 (26.6%) patients (Figure4), whereas 63 patients (4.6%) had concomitant diabetes (Figure 5). The proportion of patients with STB accompanied by PTB or diabetes did not differ significantly over the 10 study years (P > 0.05). Among other complications, two patients with thoracolumbar STB had accompanying renal TB and one with cervical STB had accompanying lymph node TB. None of the patients in this study were HIV-positive.Figure 4
Number of patients with and without concomitant PTB in each year.Figure 5
Number of patients with and without concomitant diabetes in each year.Correlations between various variables and STB and PTB are shown in Table4. Of the patients with PTB, 63.4% were males, 70.8% had accompanying abscesses, 37.7% had STS, 56.6% had accompanying neurological damage, and 61.2% received non-surgical treatment only. Sex, abscess, STS, neurological injury, and surgery were positively correlated with PTB (P < 0.05). The cure rate did not differ significantly between patients with and without PTB (P > 0.05).Table 4
Correlation analysis between STB and PTB.
Variate Type Without PTB With PTB Total χ2 P N % N % Gender Male 573 56.6 232 63.4 805 5.068 0.024 Female 439 43.4 134 36.6 573 Abscess Yes 644 63.6 259 70.8 903 6.047 0.014 No 368 36.4 107 29.2 475 Surgery Yes 776 76.7 224 61.2 1000 32.347 0.000 No 236 23.3 142 38.8 378 Systemic toxicity symptoms Yes 305 30.1 138 37.7 443 7.055 0.008 No 707 69.9 228 62.3 935 Neurological injury Yes 480 47.4 207 56.6 687 8.955 0.003 No 532 52.6 159 43.4 691 Prognosis Cure 891 88.0 319 87.2 1214 0.490 0.484 Others 121 12.0 47 12.8 163Of the patients with concomitant diabetes, 87.3% were middle-aged or older, 44.4 % had STS, 46.0% required non-surgical treatment only, and the cure rate was 76.2% (Table5). Age, STS, surgery and prognosis were correlated with the presence of diabetes (P < 0.05).Table 5
Correlation analysis between STB and diabetes.
Variate Type Without diabetes With diabetes Total χ2 P N % N % Age (yeas) >45 662 50.3 55 87.3 717 32.904 0.000 ≦45 653 49.7 8 12.7 661 Systemic toxicity symptoms Yes 415 31.6 28 44.4 443 4.576 0.032 No 900 68.4 35 55.6 935 Surgery Yes 966 73.4 34 54.0 1000 11.474 0.001 No 349 26.6 29 46.0 378 Prognosis Cure 1167 88.7 48 76.2 1215 9.086 0.003 Others 148 11.3 15 23.8 163


## 3.6. Comparison of Data according to Time Period

Comparisons of data in the first and second group of 5 years are shown in Table6. Group A (January 2007–December 2011) comprised 654 patients and Group B (January 2012–December 2016) 724. There was a greater proportion of patients aged over 60 years, urban patients, and medical staff with STB in Group B than in Group A (P < 0.05), the proportion of older patients, urban patients, and medical staff with STB having increased by 6.1%, 5.2%, and 1.3%, respectively.Table 6
Comparison of 10 years' data.
Variate Type Group A Group B Total χ2 P (2007-2011) (2012-2016) N % N % Gender Male 378 57.8 427 59 805 0.197 0.657 Female 276 42.2 297 41 573 Age (yeas) ≦60 526 80.4 538 74.3 1064 7.312 0.007 >60 128 19.6 186 25.7 314 Residence Rural 494 75.5 509 70.3 1003 4.747 0.029 Urban 160 24.5 215 29.7 375 Occupation Medical staff 6 0.9 16 2.2 22 4.154 0.046 Others 648 99.1 708 97.8 1356 Back pain Yes 596 91.1 679 93.8 1275 3.497 0.061 No 58 8.9 45 6.2 103 Radicular pain Yes 264 40.4 288 39.6 552 0.049 0.825 No 390 59.6 436 60.4 826 Systemic toxicity symptoms Yes 215 32.9 228 31.5 443 0.301 0.583 No 439 67.1 496 68.5 935 Abscess Yes 429 65.6 474 65.5 903 0.002 0.964 No 225 34.4 250 34.5 475 Neurological injury Yes 339 51.8 348 48.1 687 1.952 0.162 No 315 48.2 376 51.9 691 Involved number of vertebrae <3 509 77.8 549 75.9 1058 0.771 0.380 ≧3 145 22.2 175 24.1 320 Surgery Yes 488 68.5 512 70.7 1000 2.625 0.105 No 166 31.5 212 29.3 378 PTB Yes 176 26.9 190 26.2 366 0.079 0.779 No 478 73.1 534 73.8 1012 Diabetes Yes 23 3.5 40 5.5 63 3.176 0.075 No 631 96.5 684 94.5 1315 Prognosis Cure 567 86.7 648 89.5 1215 2.593 0.107 Others 87 13.3 76 11.9 163


## 4. Discussion

According to a 2017 WHO report [1], 603,000 male and 292,000 female patients were newly diagnosed with TB in China, this male to female ratio being 2.1:1. In the present study, the male to female ratio of the 1378 patients with STB was 1.4:1, and there was no significant change in that ratio over the 10 years of the study. Young and middle-aged adults (18–60 years old) accounted for 1378 (69.9%) of the patients with STB. This age group provides the main labor force, which is important in that long-term physical labor increases the load on and activity of the spine, resulting in chronic spinal damage, thus increasing susceptibility to MTB. Children had the lowest incidence (7.3%), which may be attributable to the protective effect of BCG inoculation, which is sustained into adolescence [7].In 2010, the fifth national TB survey showed an increase in the number of older patients with bone and joint TB [8], and in the present study we found that the number of patients aged >60 years increased significantly over time. This increase in older patients may be associated with the aging of the general population [9], lengthening lifespans, poor immunological function, and the increased number of comorbidities in this age group [10]. In addition, STB in older persons is characterized by complexity, disease, slow recovery, resistance to treatment, and atypical symptoms [11]. This trend has hampered developments in public health and social conditions and increased difficulties in prevention and treatment of STB.Worldwide, 80% of patients with STB are in developing countries and poverty-stricken areas. In China, 80% of patients with STB are in rural areas [8]. In this study, 72.8% patients were from rural areas, which are associated with poor economic level and poor medical and health conditions. The proportion of urban patients with STB increased from 24.5% to 29.7% between the two five-year periods of the present study; this may be related to the increasing proportion of Chinese persons in urban areas. Developments in transportation and increases in population mobility may have contributed to this change. We identified more patients with STB in Changsha, Shaoyang, Yueyang, and Yiyang than in other cities of Hunan province. Possible reasons for this discrepancy may include comprehensive factors affecting the availability of treatment, the population of each city, and variations in economic situation between regions. Thus, screening for STB is recommended for improving prevention, early diagnosis, and treatment of STB in the cities with a high incidence of this condition.In this study, 66.6% of the patients were farmers and manual workers, who had been engaging in stooped labor, which may increase the prevalence of STB. It is worth noting that the incidence of medical staff increased significantly (P < 0.05) over the 10 years of the study. Medical staff are exposed to patients with diagnosed or suspected TB, which confers a high risk of TB infection [12].Back pain is the most frequent symptom of STB [13]. Such pain is typically localized to the site of involvement, which is most commonly the thoracic and lumbar spine. In one study, chronic back pain was the only symptom in 61% of patients with STB [3]. In the present study, 92.5% of inpatients had pain at the site of lesion and this was the main reason for patients seeking medical evaluation and treatment. The mechanisms by which STB causes pain are as follows. First, pain may be caused by spinal instability due to destruction of the vertebral body. Second, neuropathic pain may result from inflammatory stimuli associated with TB lesions, such as abscesses and necrotic bone. Radicular pain was present in 40.1% of our patients as a result of inflammatory stimuli of nerve root. STS of TB, indicating presence of active disease, are present in approximately 20%~30% of patients with osteoarticular TB [13]. In this study, 32.1% of patients presented with STS of TB, including low fever, fatigue, emaciation, and night sweats. High fever may also occur during the acute phase of TB. Typical STS of TB can contribute to the diagnosis of STB; however, 67.9% of our patients lacked such symptoms.STB is prone to cause neurological injury and the rate of disability is high. The incidence of neurological impairment in patients with STB reportedly varies from 23% to 76% [14]. In this study, 49.9% patients had neurologic impairment, 1.5% of them having ASIA Grade A and 2.8% Grade B, which represent severe neurologic damage. Patients with STB and neurologic impairment often need surgical treatment to create space to enable nerve recovery. Impaired neural function can recover to different degrees after surgery; however, recovery in patients with severe neurologic impairment is characteristically poor.STB often involves two vertebrae because the segmental arteries bifurcate to supply two adjacent vertebrae. Spread of MTB beneath the anterior or posterior longitudinal ligaments can also result in involvement of multiple contiguous vertebrae. In this study, 67.9% of patients had two involved adjacent vertebrae, which comprised one motion segment. The most frequently involved vertebrae were lumbar, followed by thoracic. This localization may be related to the anatomical factors of high level of mobility and load forces in the lumbar region and the long segments in the thoracic region. The incidence was only 0.8% in sacrococcygeal vertebrae, likely because of its short segments, low mobility, and low load forces. Abscess formation around a vertebral lesion, which is not uncommon and prone to extreme enlargement, is another characteristic feature of STB. In this study, 65.5% of patients had abscesses. The 34.5% without abscesses may be more difficult to diagnose. Differential diagnoses include other diseases that cause bone destruction, such as spinal tumors.Anti-TB drug treatment is the gold standard for the treatment of STB, whereas surgical treatment plays an important role as adjuvant therapy. The aim of surgery is to completely remove a lesion, achieve spinal decompression, reconstruct spinal stability, and restore a normal spinal sequence [15]. In this study, 72.6% of inpatients underwent surgery and their cure rate was as high as 88.2%. The relapse rate was 3.5% (49 patients). Reasons for recurrence may include erratic anti-TB drug treatment, malnutrition, comorbidities, and inadequate rest. The patients with relapses were all cured by revision surgery, including debridement, drainage, and focal catheter infusion with anti-TB drugs.Five percent of patients with PTB reportedly have accompanying STB [16, 17]. Approximately 33%–50% of patients with STB have an associated primary lung focus or report a history of PTB [18]. In our study, 26.6% of patients with STB had accompanying PTB. We found that concomitant STB and PTB had the following characteristics. This combination was more common in male patients and was associated with abscesses, STS, neurological injury, and non-operative treatment. The influence of smoking, drinking and other lifestyle factors [19] may account for the predominance of PTB in men. Given that the STS of fever and night sweats are commonly present in patients with PTB, it is unsurprising that they are also common in patients with STB and PTB. The probability of abscess and neurological injury may be related to the extent of lesion; the specific reasons need further study. Patients with STB complicated by active PTB are prone to undergo conservative treatment. Surgery may cause spread of MTB.The prevalence of TB was three to six times higher in patients with diabetes than in those without diabetes; additionally, the incidence of TB was three times higher in patients with poorly controlled diabetes than in those with ideally controlled diabetes [20]. Active TB, being an infection, can aggravate diabetes and may even induce acute ketoacidosis. Patients with diabetes and TB usually have the characteristics of long course, severe illness, rapid progression, and slow rehabilitation, which make treatment difficult [21, 22]. Moreover, patients with diabetes and STB have impaired anti-infection and tissue repair ability. Internal fixation and implants [23] are often needed for STB surgery. Active infection often exacerbates the patient’s condition and affects the prognosis, sometimes leading to failure of surgery [24]. In our study, 63 patients (4.6%) had accompanying diabetes. We found that patients with STB and diabetes had the following characteristics. They were more commonly aged over 45 years and were prone to have STS and undergo non-surgical treatment. In addition, their prognosis was relatively poor. If surgery is needed in these patients, attention should be paid to the following: infection, wound healing [25], osteoporosis [26], stability of internal fixation [27] and vascular lesions [28].The following limitations of this study are worth noting. First, the number of patients was relatively small and they were all inpatients. Because data on them is inadequate and difficult to obtain, outpatients were not included in this study; this may have resulted in a bias in outcomes, such as the higher rate of surgery and no HIV/AIDS case. Second, results of tests for drug resistance were unavailable.


## 5. Conclusions

STB remains a severe problem endangering the public health and cannot be ignored. Most patients ignore its symptoms and therefore receive untimely treatment. Thus, surveillance for and treatment of STB should be strengthened in south-central China. In addition to the existing database for PTB, a database of patients with STB should be set up throughout China.



---

*Source: 9765253-2019-03-03.xml*